GlaxoSmithKline plc (the Company) announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2012 it purchased 400,000 of its Ordinary Shares of 25 pence each (shares) on 6 August 2012.
The highest price paid per share was 1509.5 pence per share.
The lowest price paid per share was 1487 pence per share.
The Company intends to hold these shares in Treasury.
The Company holds 484,607,927 of its shares in Treasury, representing 8.86% of the total issued share capital of the Company.
Including shares which have been purchased but not yet settled, the Company holds 486,507,927 of its shares in Treasury, representing 9.76% of the current total voting rights in the Company.
The Company has 4,985,737,903 shares in issue (excluding shares held in Treasury). This number represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.
This announcement does not constitute, or form part of, an offer or any solicitation of an offer to purchase or subscribe for securities in any jurisdiction and is in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
This information is provided by RNS
The company news service from the London Stock Exchange
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.